Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration

Exclusion Criteria

• •1. past intravitreal anti-vascular endothelial growth factor therapy in the study eye
• •2. past intravitreal or subtenon injection of steroid therapy in the study eye
• •3. past vitrectomy therapy in the study eye
• •4. infection or suspicion of infection in eyes or periocular region
• •5. severe intraocular inflammation in eyes
• •6. past allergic reaction for ranibizumab
• •7. past allergic reaction for fluorescein, indocyanine green or iodine
• •8. pregnancy (positive pregnancy test) or lactating women
• •9. other conditions that the investigator believed would pose a significant hazard to the subject if investigational therapy were initiated.